Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant MS4A1 (Rituximab Biosimilar) antibody

This Mouse Monoclonal antibody specifically detects MS4A1 (Rituximab Biosimilar) in FACS and in vivo. It exhibits reactivity toward Human.
Catalog No. ABIN7795085
-15% Promotion 2026
$653.85
$769.23
save $115.38 (-15 %)
Plus shipping costs $50.00
5 mg
Shipping to: United States
Delivery in 6 to 8 Business Days

Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) antibody (ABIN7795085)

Target

MS4A1 (Rituximab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

  • 8
  • 2
  • 2
Human

Host

  • 3
  • 3
  • 1
  • 1
Mouse

Clonality

  • 5
  • 3
Monoclonal

Conjugate

  • 8
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated

Application

  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Rituximab Biosimilar, Endotoxin 0.05 EU/mg

    Characteristics

    B-lymphocyte antigen CD20 encoded by the MS4A1 gene is an activated-glycosylated phosphoprotein on the surface of all B-cells. The function of the membrane protein is to stimulate B-cell immune response, specifically against T-independent antigens though its natural ligand remains unknown. CD20 is important for the development and differentiation of B-cells into plasma cells. CD20 belongs to the membrane-spanning 4A family with common structural features, similar intron/exon splice boundaries, and unique expression patterns among hematopoietic cells and nonlymphoid tissues. Rituximab, a chimeric anti-CD20 monoclonal antibody, destroys B cells and is used to treat diseases with excessive numbers of B cells, overactive B cells, or dysfunctional B cells, such as many lymphomas, leukemias, transplant rejection, and autoimmune disorders.

    Purification

    Protein A or G affinity column

    Purity

    >95 % by reducing SDS-PAGE

    Endotoxin Level

    Less than 0.5 EU/mg of protein as determined by LAL method

    Immunogen

    Human lymphoblastoid cell line SB
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Storage

    4 °C,-20 °C

    Storage Comment

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    MS4A1 (Rituximab Biosimilar)

    Alternative Name

    Rituximab Biosimilar

    Target Type

    Biosimilar
You are here:
Chat with us!